Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CSCC_ASC (Seoul National University Hospital)
- Development stage
- Unknown
- Lead developer
- Seoul National University Hospital
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intralesional
01
Overview
**CSCC_ASC** is an investigational allogeneic adipose-derived mesenchymal stem cell therapy developed by Seoul National University Hospital for chronic, intractable lateral epicondylitis. The product is administered by ultrasound-guided intratendinous injection into hypoechoic lesions of the common extensor tendon, with fibrin glue used as a local delivery matrix. It is intended to promote tendon repair through the regenerative, trophic, anti-inflammatory, and immunomodulatory activities of donor-derived mesenchymal stromal cells. In a pilot study, injections of 1 million or 10 million cells were associated with improvements in pain, elbow performance, and sonographic tendon defects through 52 weeks, without significant treatment-related adverse effects reported. ([academic.oup.com](https://academic.oup.com/stmcls/article/33/10/2995/6407352))
- Other names
- ALLO-ASCallogeneic adipose-derived mesenchymal stem cellsallogenic adipose-derived mesenchymal stem cells
Beyond the preview
Go deeper on CSCC_ASC (Seoul National University Hospital).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CSCC_ASC (Seoul National University Hospital).